Abstract:Advanced glycation end products (AGEs) boost the generation of reactive oxygen species (ROS) in glomerular mesangial cells (GMCs), and thereby play important roles in diabetic nephropathy (DN). Sirtuin 1 (Sirt1), a protein deacetylase, is known to markedly protect cells from oxidative stress (OSS) injury. Based on the critical involvements of AGEs and Sirt1 in OSS, Sirt1 is postulated to resist AGEs-induced diabetic renal fibrosis through its antioxidative effects. The current study was designed to explore the inhibitory effect of Sirt1 on the expressions of fibronectin (FN) and transforming growth factor-β1 (TGF-β1) induced by AGEs in GMCs. The molecular mechanism by which Sirt1 promoted the activation of the antioxidative pathway was further investigated. The following findings were obtained: (1) the treatment of GMCs with AGEs decreased Sirt1 levels in terms of protein expression and activity but increased FN and TGF-β1 levels in a dose- and time-dependent manner; (2) resveratrol or Sirt1 overexpression markedly increased Sirt1 levels and reduced FN and TGF-β1 expressions; (3) inhibition of Sirt1 activity further induced the productions of FN and TGF-β1; (4) Sirt1 promoted the nuclear accumulation, DNA binding, and transcriptional activities of Nrf2 and upregulated the expressions of Nrf2 downstream genes, heme oxygenase-1, and superoxide dismutase 1; ROS levels induced by AGEs eventually reduced in a deacetylase-dependent manner; and (5) with the deposition of AGEs in the kidneys, the diabetic rats suffered severe renal dysfunction and high OSS levels; resveratrol treatment evidently diminished the OSS levels, ameliorated renal injury, and prevented the expressions of FN and TGF-β1 in the kidneys of diabetic rats. This work supports a negative role of Sirt1 in AGE-induced overproductions of FN and TGF-β1. The molecular mechanisms that underlie the beneficial effects of Sirt1 on DN correlate well with the activation of the Nrf2/ARE antioxidative pathway.

Sirt1 inhibits renal tubular cell epithelial–mesenchymal transition through YY1 deacetylation in diabetic nephropathy

YY1: A Novel Therapeutic Target for Diabetic Nephropathy Orchestrated Renal Fibrosis.

SRT1720 retards renal fibrosis via inhibition of HIF1α /GLUT1 in diabetic nephropathy.

Sirt1 activation prevents high glucose-induced angiotensin converting enzyme 2 downregulation in renal tubular cells by regulating the TIMP3/ADAM17 pathway

YY1 inactivated transcription co-regulator PGC-1a to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis ( Apr, 10.1007/s10565-022-09711-7, 2022)

YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis

Renal protective effect of sirtuin 1

Correction to: YY1 inactivated transcription co‐regulator PGC‐1α to promote mitochondrial dysfunction of early diabetic nephropathy‐associated tubulointerstitial fibrosis

Inactivation of TSC1 Promotes Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells in Mouse Diabetic Nephropathy

Connexin 43 Prevents the Progression of Diabetic Renal Tubulointerstitial Fibrosis by Regulating the SIRT1-HIF-1α Signaling Pathway

Inhibition of the SIRT1 Signaling Pathway Exacerbates Endoplasmic Reticulum Stress Induced by Renal Ischemia/reperfusion Injury in Type 1 Diabetic Rats

Sirt1 Resists Advanced Glycation End Products-Induced Expressions of Fibronectin and TGF-β1 by Activating the Nrf2/ARE Pathway in Glomerular Mesangial Cells.

Effects of the S1P/S1PR1 Signaling Pathway on High Glucose-Induced NRK-52E Epithelial-Mesenchymal Transition Via Regulation of ROS/NLRP3

High Glucose Upregulates Endothelin Type B Receptors in Vascular Smooth Muscle Cells Via the Downregulation of Sirt1.

Loss of Sirt1 promotes exosome secretion from podocytes by inhibiting lysosomal acidification in diabetic nephropathy

SIRT1-dependent deacetylation of Txnip H3K9ac is critical for exenatide-improved diabetic kidney disease

SIRT1 Attenuates High Glucose-Induced Insulin Resistance Via Reducing Mitochondrial Dysfunction in Skeletal Muscle Cells.

Sirt1 is Essential for Resveratrol Enhancement of Hypoxia-Induced Autophagy in the Type 2 Diabetic Nephropathy Rat

Epigenetic mechanisms of nephroprotection in diabetic nephropathy: focus is on sirtuin-1

Protein arginine methyltranferase-1 induces ER stress and epithelial-mesenchymal transition in renal tubular epithelial cells and contributes to diabetic nephropathy

SIRT3 Prevents Angiotensin II-induced Renal Tubular Epithelial-Mesenchymal Transition by Ameliorating Oxidative Stress and Mitochondrial Dysfunction.